MedPath

A study on the relevance between sleep apnea syndrome and heart failure in non-obstructive hypertrophic cardiomyopathy with left ventricular function maintained

Not Applicable
Suspended
Conditions
Hypertrophic cardiomyopathy
Registration Number
JPRN-UMIN000036187
Lead Sponsor
ational Hospital Organization Yokohama Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Having treated by oral appliance (OA), CPAP, Adaptive Servo-Ventilation (ASV), Bi-level positive airway pressure (BiPAP), and surgical treatment at the time of registration (2)Diagnosed with secondary myocardial hypertrophy such as Fabry disease (3) Hospitalized for decompensated heart failure at registration (4)Undergoing ventricular resynchronization therapy (Cardiac Resynchronization Therapy: CRT) (5) With a history of open heart surgery such as artificial valve replacement surgery accompanying pericardiotomy (6)With left ventricular outflow tract gradient >= 30 mmHg (7) With dilated hypertrophic cardiomyopathy (defined as with left ventricular ejection fraction <40%) (8)With malignant tumor complications (9)Judged by the attending physician as inappropriate to participate in this study due to chronic hepatitis or cirrhosis (10) Same as above, except due to pulmonary fibrosis accompanied by elevation of either KL-6, SP-D or SP-A (11) Same as above, except due to rheumatoid arthritis (12)Judged by the principal investigator or sub-investigators as inappropriate for participation in this study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath